203 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
20 Mar 24
RepliCel announces a Letter of Intent for Asset Purchase Agreement
4:38pm
Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
of the Company have been prepared by and are the responsibility of the Company's management.
The Company's independent auditor has not performed a review
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
of the Company have been prepared by and are the responsibility of the Company's management.
The Company's independent auditor has not performed a review
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
19 Oct 23
Current report (foreign)
1:45pm
Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
4 Oct 23
RepliCel Provides Default Status Update and Announces Shareholder Approval of Equity Incentive Plan
2:23pm
.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.1
8o4tdvxbes
13 Sep 23
RepliCel Announces DermaPreciseā¢ Development Milestone, Updates Arbitration Proceedings
5:32pm
6-K
EX-99.2
h9mzek5jsmj9awzvkmv
13 Sep 23
RepliCel Announces DermaPreciseā¢ Development Milestone, Updates Arbitration Proceedings
5:32pm
6-K
EX-99.1
ec0n2d
7 Sep 23
Current report (foreign)
12:26pm
6-K
EX-99.2
y7twms7jacv8cfa1v0ko
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
6-K
EX-99.1
wya905tptl03
29 Aug 23
RepliCel announces the passing of long time Chief Financial Officer Simon Ma; David Kwok is appointed Chief Financial Officer
1:14pm
6-K
EX-99.2
b5rr72a
17 Aug 23
Annual General and Special Meeting
11:22am
6-K
EX-99.4
mohp9jlsnnv9oax
17 Aug 23
Annual General and Special Meeting
11:22am
6-K
EX-99.1
oke4aw49l19je e2o4g
9 Aug 23
Statement of Executive Compensation
7:41pm
6-K
EX-99.1
7gj41is3
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.1
jrq2d
18 May 23
RepliCel Applies to Extend Warrant and Stock Option Expiry Dates and Announces Grant of Stock Options
1:58pm
6-K
EX-99.5
xko8q4w
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
qz7gg0
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.2
7tey1ww v5jf8gvu8pe
25 Oct 22
Current report (foreign)
12:27pm
6-K
EX-99.1
4x7 z05ax661edj6
25 Oct 22
Current report (foreign)
12:27pm